mammalian
cell
expos
wide
array
complex
glycoconjug
surfac
carbohydr
structur
play
critic
role
multipl
key
cellular
event
sever
character
weak
multival
carbohydrateprotein
interact
thu
multiantennari
glycan
glycoprotein
polysaccharid
patch
glycolipid
constitut
first
line
weak
contact
pathogen
bear
correspond
carbohydraterecognit
domain
crd
cellcel
commun
also
appli
carbohydr
signal
spite
ubiquit
phenomena
basic
carbohydr
structur
recogn
carbohydratebind
protein
surprisingli
simpl
best
trior
tetrasaccharid
moieti
deepli
involv
protein
activ
site
unless
conform
epitop
invol
addit
sever
protein
interact
mechan
util
limit
set
similar
sugar
thu
rais
issu
select
instanc
innat
immun
system
exploit
structur
mannosid
yeast
fungi
bacteria
mannosebind
protein
mbp
first
defens
mechan
type
infecti
agent
yet
dendrit
cell
macrophag
hepatocyt
also
util
mannosid
pathogen
cellular
recognit
activ
paradox
bacteria
fimbriat
escherichia
coli
e
coli
possess
protein
tip
fimbria
fimh
also
recogn
bind
mannosid
host
human
tissu
premis
bacteri
infect
obvious
sole
carbohydr
structur
taken
individu
could
account
larg
multival
interact
solicit
given
glycan
consequ
valenc
geometri
topograph
saccharid
arrang
must
key
high
select
affin
observ
question
mind
glycodendrim
born
address
fundament
aspect
multival
carbohydrateprotein
interact
could
resolv
glycopolym
moreov
dendrim
assembl
infinit
varieti
chemic
architectur
expos
number
carbohydr
moieti
may
also
constitut
arsen
new
therapeut
agent
well
use
specif
cell
target
bacteri
resist
establish
chemotherapi
major
medic
issu
novel
principl
treatment
infecti
agent
thu
highli
attract
one
possibl
would
inhibit
attach
infect
pathogen
host
cell
surfac
attach
often
prerequisit
later
stage
infect
colon
invas
specif
human
tissu
sinc
chemic
structur
adhes
inhibitor
like
would
quit
similar
natur
attach
ligand
use
pathogen
agent
unlik
resist
mutat
would
give
capabl
overcom
inhibitori
effect
antiadhes
drug
without
impair
abil
adher
host
cell
glycodendrim
therefor
definit
suitabl
inhibit
bacteri
adhes
host
tissu
figur
review
highlight
moststudi
carbohydrateprotein
interact
involv
mannosid
obvious
principl
also
appli
key
interact
may
subject
review
case
galactosebind
protein
eg
galectin
mention
glycopolym
constitut
use
tool
studi
multival
interact
howev
detract
fundament
understand
glycosid
cluster
effect
glycodendrim
correspond
glycoclust
perfectli
design
address
proper
question
permit
structur
refin
ultim
could
integr
polym
even
dendron
glycopolym
chapter
therefor
also
illustr
synthet
strategi
use
wonder
design
mannosidebear
glycodendrim
wide
varieti
protein
bind
dmannopyranosid
residu
includ
highmannos
oligosaccharid
plant
lectin
particularli
concanavalin
cona
dioclea
grandiflora
pea
lectin
extens
studi
point
view
xray
crystallograph
analysi
isotherm
titrat
microcalorimetri
ic
well
fundament
aspect
relat
multival
interact
glycodendrim
bind
particular
interest
review
bind
mannosid
human
monoclon
antibodi
recogn
man
glcnac
relat
cyanovirinn
isol
cyanobacterium
nostoc
ellipsosporum
mbp
innat
immun
system
dcsign
dendrit
cellspecif
grab
nonintegrin
adhes
molecul
present
dendrit
cell
respons
bind
tlymphocyt
human
mannos
receptor
resid
macrophag
final
bacteria
fimbriat
type
protein
present
e
coli
klebsiella
pneumonia
pseudomona
aeruginosa
salmonella
spp
serratia
marcescen
shigella
flexneri
relat
mannosidebind
protein
discuss
herein
includ
urtica
dioica
agglutinin
uda
scytovirin
scilla
campanulata
lectin
scl
narcissu
pseudonarcissu
lectin
npl
galanthu
nivali
agglutinin
gna
jacalin
myrianthu
holstii
lectin
myrianthin
mhl
figur
illustr
crystal
structur
neutral
human
antibodi
bound
oligomannosid
man
glcnac
present
silent
face
envelop
glycoprotein
antibodi
adopt
unusu
domainswap
dimer
structur
origin
interdigit
fab
domain
interestingli
oligomannosid
similarli
bound
activ
site
cyanovirin
figur
cyanovirin
prefer
branch
mannosid
antibodi
local
mancmand
mand
area
consequ
sever
group
involv
synthet
design
properli
orient
mannosid
cluster
vaccin
purpos
result
vaccin
trigger
specif
highaffin
antibodi
carbohydr
portion
hiv
besid
wellstudi
galgalnac
asialoglycoprotein
hepatocyt
receptor
asgpr
still
crystollograph
data
known
case
cyanovirin
produc
bluegreen
alga
nostoc
ellipsosporum
may
well
repres
anoth
typic
role
model
complex
multival
interact
monomer
protein
cyanobacteri
protein
potent
inactiv
strain
hiv
simian
immunodefici
viru
siv
level
envelopemedi
fusion
virtu
strong
interact
hiv
surfac
envelop
glycoprotein
current
preclin
investig
topic
antivir
microbicid
protein
high
lowaffin
bind
site
highmannos
oligosaccharid
two
bind
site
apart
thu
singl
man
glcnac
residu
small
provid
chelat
effect
two
activ
site
simultan
figur
illustr
xray
structur
protein
bound
man
glcnac
highaffin
site
togeth
bound
conform
saccharid
remain
lowaffin
bind
site
readili
accommod
smaller
oligomannosid
protein
thu
constitut
good
case
studi
multival
mannosid
contain
glycodendrim
human
mannosebind
protein
hmbp
member
collectin
famili
molecul
play
role
first
line
host
defens
found
serum
mani
mammalian
speci
protein
mediat
immunoglobulinindepend
defens
reaction
pathogen
action
occur
within
minut
exposur
infecti
agent
provid
immedi
defens
day
lag
period
requir
induct
specif
antibodi
mbp
function
recogn
oligomannos
cell
surfac
variou
bacteria
virus
bind
neutral
complementmedi
cell
lysi
facilit
recognit
phagocyt
figur
upon
exposur
pathogen
concentr
mbp
serum
increas
patient
reduc
level
mbp
due
point
mutat
mbp
gene
show
propens
repeat
sever
bacteri
infect
mpb
also
act
inhibitor
human
immunodefici
viru
influenza
viru
presum
bind
highmannos
carbohydr
viral
envelop
glycoprotein
block
attach
host
cell
observ
clearli
show
import
mbp
innat
immun
system
structur
hmbp
consist
ident
subunit
arrang
hexam
trimer
adopt
bouquetlik
structur
figur
subunit
chain
consist
four
distinct
region
includ
cysteinerich
region
collagenlik
region
neck
region
crd
calcium
depend
common
featur
mbp
oligomer
possibl
disulfid
bond
cysteinerich
region
due
characterist
properti
collagenlik
domain
neck
region
tend
form
trimer
cluster
three
crd
close
proxim
significantli
increas
affin
small
sugar
cluster
impact
cluster
ensur
molecul
bind
high
affin
dens
sugar
array
like
one
found
surfac
bacteria
virus
hmbp
form
oligomer
bouquet
cruciform
structur
trimer
subunit
compos
three
polypeptid
chain
coil
collagen
triplehel
arrang
trimer
domain
orient
crd
ligandbind
site
apart
center
trimer
figur
thu
simultan
ligat
three
bind
site
could
achiev
singl
molecul
rather
elong
branch
oligosaccharid
found
cell
wall
yeast
certain
gramneg
gramposit
organ
envelop
glycoprotein
human
immunodefici
viru
shown
bind
mbp
suggest
crd
site
ideal
configur
multival
interact
therebi
increas
bind
affin
hmbp
pathogen
group
involv
design
optim
mannosid
trimer
provid
potent
chelat
hmbp
better
understand
differenti
interact
protein
highmannos
bind
protein
dominiqu
r
roy
r
unpublish
data
cterminu
crd
similarli
hmbp
oligomer
homotetram
thu
expos
four
crd
addit
dcsign
organ
microdomain
within
lipid
raft
plasma
membran
level
thu
act
dock
site
pathogen
interact
lectin
branch
oligomannosid
present
pathogen
glycoprotein
repres
anoth
interest
complex
multival
phenomena
inhibit
interact
may
potenti
repres
antivir
therapi
dendrit
cell
well
macrophag
antigenpres
cell
abl
stimul
tlymphocyt
respons
present
antigen
within
context
major
histocompat
mhc
class
ii
complex
henc
research
use
mannosid
receptor
target
potenti
vaccin
anoth
repres
member
famili
mannos
receptor
present
membraneassoci
protein
human
peripher
bone
marrow
macrophag
protein
also
constitut
multidomain
interact
mannosyl
ligand
achiev
cooper
bind
involv
eight
crd
mannosid
receptor
mediat
intern
solubl
microorganismbear
mannosid
residu
receptor
regul
level
endogen
glycoprotein
contribut
clearanc
potenti
harm
pathogen
take
part
innat
immun
regul
linear
mannosidebear
llysin
backbon
expos
six
aryl
mannosid
residu
analog
glycodendrimerbas
structur
discuss
shown
biessen
et
al
affin
low
nanomolar
rang
critic
step
hosttissu
colon
biofilm
format
achiev
bacteri
adhes
commonli
mediat
carbohydratebind
lectinlik
protein
express
shede
bacteri
surfac
type
fimbria
common
type
adhes
appendag
e
coli
sever
enterobacteria
mediat
mannosespecif
adhes
via
kda
lectinlik
subunit
fimh
crystal
structur
fimh
uropathogen
e
coli
primarili
caus
pyelonephr
solv
togeth
methyl
admannopyranosid
well
hydrophob
butyl
admannopyranosid
strongest
monoval
inhibitor
known
date
fimh
heptyl
admannopyranosid
k
thu
eight
time
better
known
pnitrophenyl
ad
mannopyranosid
pnpaman
k
four
time
better
methyl
umbelliferyl
adman
k
tabl
show
rel
affin
k
dg
seri
synthet
mannosid
deriv
figur
fimh
e
coli
measur
surfac
plasmon
reson
among
seri
alkyl
mannosid
test
methyl
octyl
increas
ethyl
higher
homolog
steadi
increas
heptyl
mannosid
k
start
increas
also
notic
hydrophob
aglycon
best
candid
flank
two
tyrosin
residu
tyr
activ
site
figur
may
provid
rational
observ
two
decad
ago
high
affin
ochloropnitrophenyl
admannosid
strain
e
coli
inde
figur
crystal
structur
trimer
hmbp
highmannos
glycan
yellow
sphere
calcium
sheriff
person
commun
inhibit
yeast
aggreg
bacteria
compound
show
rel
inhibitori
behavior
time
better
refer
compound
respect
figur
recent
studi
laboratori
unpublish
data
small
librari
mannosid
analog
construct
build
qsar
model
fimh
librari
includ
sever
clink
mannosid
cpd
almost
equival
pnp
aman
cglycosid
valuabl
candid
vivo
assay
sinc
stabl
physiolog
condit
moreov
suitabl
function
manipul
encount
typic
glycodendrim
synthes
opinion
potent
glycodendrim
construct
use
best
monoval
aglycon
togeth
optim
scaffold
valenc
linker
distanc
factor
necessarili
vari
one
receptor
anoth
glycodendrim
interest
class
synthet
welldefin
biomacromolecul
initi
design
address
issu
lowaffin
carbohydrateprotein
interact
encount
mani
biolog
relev
situat
initi
thought
expand
understand
classic
glycosid
figur
differ
mannosid
deriv
rel
inhibitori
properti
interact
fimbriat
e
coli
agglutin
yeast
adher
epitheli
cell
respect
number
parenthes
cluster
effect
origin
propos
c
lee
pioneer
glycoconjug
chemistri
biochemistri
widespread
version
usual
assum
glycosid
cluster
effect
sourc
enhanc
affin
given
multival
glycosid
toward
crd
fulli
occupi
one
activ
site
time
glycodendrim
like
typic
treelik
organ
dendrim
may
take
sever
structur
architectur
prepar
dendron
wedg
structur
spheric
globular
dendrim
even
polymerdendrim
hybrid
call
dendron
polym
report
also
describ
prepar
use
selfassembl
techniqu
base
transit
metal
complex
bipyridin
terpyridin
core
glycodendrim
synthes
diverg
converg
doublestag
converg
strategi
use
hypercor
molecul
central
element
moreov
sake
simplic
diminish
cost
inner
scaffold
portion
molecul
synthes
onepot
procedur
use
hyperbranch
polym
methodolog
achiev
base
ab
monom
system
found
commerci
avail
hyberbranch
polyglycerol
hyperbranch
polyethyleneimin
pei
boltorn
dendrim
low
dispers
construct
use
glycidol
ethylen
imin
hydroxymethyl
propion
acid
bismpa
respect
commerci
applic
glycodendrim
aris
latter
strategi
allow
lowcost
product
albeit
expens
structur
homogen
sever
dendrim
variou
surfac
function
build
block
commerci
avail
illustr
figur
polyamidoamin
dendrim
pamam
starburst
dendrit
nanotechnolog
polypropylenimin
ppi
astramol
dsm
fine
chemic
polyglycerol
boltorn
dendrim
commonli
use
pamambas
dendrim
builtin
amin
function
surfac
first
frequent
use
scaffold
sugar
attach
first
applic
use
amid
bond
format
start
sugar
lacton
although
straightforward
manipul
yet
appli
toward
mannosid
readili
applic
import
carbohydr
disadvantag
sacrif
reduc
sugar
altern
serv
extend
linker
discuss
detail
pamam
potenti
amineend
dendrim
function
carbohydr
use
thiourea
linkag
form
treat
amin
dendrim
sugar
isothiocyan
amid
linkag
carboxyl
sugar
reduct
amin
last
procedur
give
rise
mixtur
monoand
dialkyl
largest
glycodendrim
built
far
contain
mannosid
residu
prepar
gener
dendrim
basic
two
key
strategi
build
glycodendrim
figur
first
one
involv
initi
synthesi
core
molecul
diverg
process
approach
focal
multifunct
molecul
systemat
expand
outward
use
variou
chemic
linkag
instanc
pamambas
dendrim
use
odiamin
core
eg
etc
amin
treat
methyl
acryl
doubl
nalkyl
ensu
ester
react
larg
excess
provid
first
gener
bear
four
amin
function
process
alkylationamid
sequenti
repeat
heart
molecul
desir
extern
valenc
reach
sugar
append
molecul
peripheri
growth
doubli
exponenti
n
number
surfac
group
may
vari
depend
number
function
seed
molecul
exampl
etc
main
disadvantag
diverg
growth
necess
increas
number
efficaci
reaction
requir
obtain
defectfre
dendrim
otherwis
difficult
purifi
given
small
differ
size
number
function
group
second
approach
converg
growth
strategi
avoid
sever
synthet
challeng
inher
one
describ
procedur
involv
construct
glycodendron
wedg
use
follow
attach
multival
core
structur
procedur
simplifi
number
coupl
partner
reduc
minimum
particular
step
moreov
target
molecul
virtu
higher
molecular
weight
comparison
fragment
simpler
purifi
size
exclus
chromatographi
number
peripher
carbohydr
moieti
caus
steric
inaccess
eventu
limit
techniqu
nevertheless
well
establish
larg
number
surfac
carbohydr
moieti
detriment
carbohydr
access
carbohydratebind
receptor
doubli
converg
approach
also
describ
case
core
molecul
first
assembl
sever
surfac
function
group
could
directli
attach
glycodendron
addit
interest
fact
glycodendrim
synthes
solidphas
chemistri
combinatori
dynam
combinatori
method
recent
exampl
also
illustr
feasibl
use
microwav
activ
coupl
carbohydr
moieti
discuss
click
dendrim
section
first
glycodendrim
appear
literatur
built
use
diverg
solidphas
peptid
chemistri
llysin
repeat
assembl
bear
expos
sialic
acid
residu
construct
inhibit
flu
viru
attach
compet
sialosid
ligand
present
respiratori
tract
hemagglutinin
viru
particl
figur
use
dendron
eight
sialosid
surfac
roy
et
al
abl
demonstr
saccharid
residu
better
per
saccharid
basi
correspond
monom
howev
effici
polym
could
cover
effici
surfac
spheric
viral
particl
properti
well
exploit
random
coil
polym
later
argu
dendron
polym
even
potent
respect
polyllysin
scaffold
util
mannosid
residu
bear
aryl
aglycon
partli
optim
monom
result
glycondendron
happen
show
increas
inhibitori
potenc
fimbriat
e
coli
per
mannosid
basi
structur
correspond
sialo
figur
mannodendrim
figur
illustr
dendron
lysin
repres
one
wide
use
core
structur
glycodendrim
review
niederhafn
et
al
describ
synthesi
peptid
dendrim
applic
glycosyl
lysin
dendrim
prepar
solid
support
solut
reaction
peripher
amino
group
varieti
electrophil
carri
pendant
sugar
residu
lead
glycodendrim
roy
cowork
previous
report
lysin
glycodendrim
carri
varieti
carbohydr
via
thioetherif
achloroacetamid
attach
ntermin
amin
group
lysin
activ
ester
coupl
describ
provid
galactosideand
nacetylglucosaminecap
lysin
glycoclust
later
also
elabor
lewi
x
antigen
chemoenzymat
process
converg
growth
diverg
growth
figur
two
major
synthet
strategi
toward
glycodendrim
synthes
mention
dendrit
cell
macrophag
effect
antigen
present
cell
apc
sinc
cell
expos
mbp
constitut
power
candid
vaccin
target
thu
instead
associ
short
immunogen
peptid
protein
carrier
keyhol
limpet
hemocyanin
klh
bovin
serum
albumin
bsa
chang
cowork
recent
investig
possibl
use
mannosidecap
polylysin
glycodendrim
construct
ntermin
sever
immunogen
peptid
figur
peptid
sequenc
hiv
protein
bear
llsgiv
motif
capabl
inhibit
viral
fusion
sarscov
influenza
hemagglutinin
built
rink
amid
resin
lysin
moieti
introduc
lysin
dendrim
follow
mannosyl
use
butano
acid
termin
e
amino
group
lysylpeptid
dendrim
preliminari
data
vaccin
contain
llsgiv
motif
demonstr
could
elicit
polyclon
antibodi
respons
rabbit
much
stronger
klh
construct
conclud
mannosyl
dendron
stabil
antigen
peptid
protect
proteolysi
ntermin
mannosyl
peptid
carri
one
six
mannos
residu
also
shown
kone
cowork
elicit
immun
respons
effici
greater
peptid
antigen
alon
mannos
receptor
capabl
mediat
intern
solubl
particul
carbohydr
structur
take
part
innat
immun
figur
nonoptim
athiosialodendrim
bear
eight
residu
base
polylysin
core
structur
use
inhibit
flu
viru
adhes
human
erythrocyt
ic
low
mm
togeth
implic
adapt
immun
stimul
consider
effort
toward
select
deliveri
enzym
drug
oligonucleotid
gene
antigen
cell
express
therapeut
vaccin
strategi
xray
crystallograph
data
relat
rat
mannosebind
lectin
show
extens
hydrogen
bond
coordin
bond
two
equatori
vicin
group
dmannos
shown
figur
becom
clear
quinic
shikim
acid
vicin
diol
transdiequatori
pseudodiequatori
arrang
respect
could
function
mannos
isoster
strategi
extens
exploit
grandjean
cowork
design
dendrim
contain
mannos
mimet
synthet
sequenc
use
start
format
shikim
quinic
acid
amid
bond
format
e
l
lysin
peptid
bear
cystein
glycin
afford
dendron
follow
insert
fluorescein
isothiocyan
first
eamino
group
bi
clch
co
lysli
nh
balanh
final
thioether
bond
format
two
synthon
provid
desir
glycodendrim
figur
fluoresceinlabel
pseudoglycodendrim
valenc
two
eight
test
competit
inhibit
assay
mannan
evalu
confoc
microscopi
analysi
use
mannos
receptor
express
transfect
cell
cell
express
mannos
receptormedi
uptak
assay
monocytederiv
human
dendrit
cell
cytofluorimetr
analysi
synthet
cluster
shown
effect
ligand
dendrit
cell
optimum
affin
toward
cluster
valenc
four
glycomimet
perform
well
natur
mannosid
howev
result
indic
mannos
receptor
could
accommod
structur
variat
significantli
diverg
natur
ligand
vein
kiessl
cowork
synthes
solidphas
librari
glycomimet
shikim
acid
rink
amid
resin
util
solid
support
immobil
amin
coupl
sever
differ
amino
acid
ntermin
coupl
shikim
acid
amid
bond
format
conjug
nucleophil
addit
thiolat
cleavag
resin
remov
protect
group
amino
acid
side
chain
furnish
librari
compound
rel
bind
potenc
librari
member
toward
mannosebind
protein
mbpa
use
fluoresceinlabel
mbpa
measur
ten
compound
identifi
potenc
compar
even
slightli
better
meaman
figur
tomalia
cowork
pioneer
synthesi
poli
amidoamin
pamam
dendrim
figur
use
diverg
growth
procedur
describ
attract
molecul
constitut
excit
new
class
macromolecular
architectur
drawn
vast
interest
sever
research
area
commerci
avail
scaffold
extens
use
mani
group
glycochemist
figur
mannos
isost
shikim
quinic
acid
use
polylysin
dendrim
scaffold
improv
target
macrophag
dendrit
cell
group
previous
describ
easi
effici
coupl
sever
aminoend
pamam
gener
pisothiocyanatophenyl
admannopyranosid
figur
show
exampl
result
mannodendrim
use
effici
mode
coupl
isothiourea
linkag
therefor
use
sever
group
nice
exploit
lindhorst
cloning
first
four
gener
novel
class
monodispers
neoglycoconjug
mannosid
unit
evalu
ligand
phytohemagglutinin
cona
pisum
sativum
pea
lectin
use
enzymelink
lectin
assay
ella
turbidimetr
analysi
bind
properti
glycodendrim
togeth
refer
monosaccharid
determin
use
yeast
mannan
coat
antigen
peroxidaselabel
lectin
mannosyl
dendrim
demonstr
potent
inhibitor
ic
valu
time
better
monomer
methyl
admannopyranosid
taken
standard
lindhorst
cowork
also
use
thioureabridg
protect
unprotect
mannosid
deriv
figur
investig
potenc
inhibit
hemagglutin
guinea
pig
erythrocyt
type
fimbriat
e
coli
trival
cluster
increas
bind
potenc
achiev
howev
inhibitori
behavior
surpass
hexaand
octam
nonspecif
interact
hydrophob
interact
stack
effect
consid
interpret
result
reduct
amin
use
lindhorst
cowork
provid
access
glycoclust
tri
aminoethyl
amin
core
glycoclust
obtain
ethan
obtain
allyl
admannopyranosid
ozonolysi
follow
treatment
sodium
triacetoxyborohydrid
nabh
oac
figur
procedur
may
give
rise
doubl
nalkyl
excess
aldehyd
must
use
complet
complex
carbohydratebas
glycodendrim
situat
may
lead
undesir
partial
structur
circumv
stoddart
et
al
sialodendrim
synthes
target
siglec
use
n
methyl
amin
reduct
amin
similarli
okada
cowork
use
unprotect
sugarlacton
form
amid
bond
directli
amineend
pamam
dendrim
dmso
afford
secondto
fourthgener
lactodendrim
figur
discuss
strategi
equal
appli
mannosid
pieter
cowork
describ
prepar
evalu
multival
mannosid
includ
small
dival
system
glycodendrim
glycopolym
inhibitor
type
fimbriat
uropathogen
e
coli
mannosyl
surfac
group
obtain
amid
bond
format
amannopyranosid
pretreat
diglycol
anhydrid
typic
bop
tbtu
peptid
coupl
reagent
use
furnish
desir
pamamdendrim
figur
novel
easi
bioassay
set
purpos
mannosyl
dendrim
test
use
elisabas
assay
abil
inhibit
bind
mannosebind
type
fimbriat
e
coli
fimh
monolay
cell
line
deriv
human
urinari
bladder
epithelium
pamam
mannodendrim
display
highest
affin
toward
target
although
rel
potenc
per
mannos
rather
low
glycopolym
mannos
residu
per
polym
show
enhanc
activ
increas
mannos
substitut
ic
low
rel
potenc
polym
seri
per
mannosid
basi
rel
constant
around
cloning
cowork
similarli
describ
firstthrough
sixthgener
pamam
dendrim
surfac
group
mannosid
residu
thiourea
linker
compar
methyl
admannosid
taken
control
monom
dendrim
show
increas
activ
toward
phytohemagglutinin
cona
dendrim
bound
roughli
one
order
magnitud
better
methyl
mannosid
suggest
glycosid
cluster
effect
enhanc
local
concentr
small
multival
bind
occur
chelat
effect
dendrim
show
increas
activ
tetramer
con
two
order
magnitud
indic
multival
bind
occur
also
possibl
chang
shape
circular
g
g
pamam
spheric
caus
observ
bind
enhanc
note
four
mannosebind
site
cona
apart
calcium
calcium
distanc
lectin
crosslink
requir
cluster
apart
may
also
caus
increas
affin
noteworthi
fact
dimer
lectin
requir
dimer
cluster
happen
cyanovirinn
cvn
recogn
disaccharid
higher
homolog
see
discuss
present
termin
branch
high
oligomannos
structur
present
virus
microb
cloning
cowork
investig
rel
inhibitori
properti
fuction
dendrim
abil
bind
cvn
figur
order
evalu
mannosyl
dendrimercvn
interact
precipit
assay
perform
pamamfunction
dendrim
induc
precipit
cvndendrim
complex
titrat
solubl
cvn
increas
amount
dendrim
show
linear
decreas
absorb
increas
total
amount
protein
precipit
data
translat
appar
stoichiometri
cvn
dendrim
complex
respect
studi
various
load
saccharidefunction
dendrim
provid
valuabl
inform
regard
multival
bind
number
construct
report
vari
load
densiti
carbohydr
antigen
gener
highli
function
scaffold
one
highest
activ
often
lessfunction
ligand
exhibit
optim
activ
attribut
fact
high
load
saccharid
portion
becam
less
access
due
increas
steric
hindranc
anoth
hypothesi
aromat
aglycon
pstack
might
tighten
saccharid
unit
dendrim
surfac
fact
pamamdendrim
bear
aryl
mannosid
moieti
seen
figur
experi
solubl
problem
aqueou
environ
analog
experi
pamambas
sialosid
flu
viru
interact
wherein
saccharid
portion
interspac
nonsaccharid
function
cloning
cowork
describ
synthesi
heterogen
function
pamam
manno
dendrim
figur
hemagglutin
assay
perform
ad
rabbit
erythrocyt
preincub
solut
con
vari
concentr
dendrim
signific
increas
activ
fourth
fifth
sixth
dendrim
gener
maximum
activ
occur
sugar
load
gener
area
avail
per
sugar
maximum
activ
vari
slightli
differ
gener
trend
similar
case
strike
observ
highest
activ
correl
maximum
sugar
load
rather
occur
slightli
closer
pack
sugar
gener
increas
analog
load
distribut
dendrim
bear
heterogen
structur
evalu
henc
mannosidetempofunction
pamam
dendrim
synthes
epr
analysi
dendrim
suggest
dendrim
random
distribut
surfac
function
group
comparison
hemagglutin
assay
mannosid
tempoand
mannosidehydroxyfunction
dendrim
suggest
presenc
spin
label
influenc
dendrim
bind
cona
deriv
also
recent
describ
use
pamam
simultan
function
mannos
galactos
glucos
residu
figur
malditof
ms
use
determin
number
carbohydr
residu
type
dendrim
chang
mw
sequenti
addit
chang
mw
deacyl
use
associ
dendrim
cona
studi
use
precipit
hemagglutin
assay
increas
number
mannos
residu
decreas
number
glucos
residu
caus
increas
rel
activ
toward
cona
dendrim
bear
mannoseglucos
load
linear
relationship
manglc
load
assay
activ
observ
compound
gener
howev
differ
fulli
mannosefunction
dendrim
fulli
glucosefunction
dendrim
never
approach
compound
gener
mannosefunction
dendrim
fivefold
higher
rel
activ
toward
con
glucosefunction
analog
residu
constitu
repeat
unit
phosphoglycan
act
biolog
signal
particular
known
involv
select
target
newli
synthes
enzym
lysosom
known
presenc
multipl
residu
nlink
oligosaccharid
lead
bind
affin
enhanc
cationindepend
receptor
macrophag
enhanc
bind
affin
attribut
cluster
effect
light
import
glycosid
cluster
effect
carbohydrateprotein
interact
jayaraman
cowork
investig
synthesi
properti
pamam
dendrim
figur
synthesi
dendrit
initi
benzyloxycarbonylamino
ethyl
modifi
sequenti
deprotect
benzoyl
ester
trityl
primari
hydroxyl
group
benzoyl
remain
hydroxi
group
detrityl
phosphoryl
free
hydroxyl
group
chlorodimethyl
phosphat
hydrogenolysi
provid
desir
deriv
subject
amid
bond
format
preform
pamam
dendrim
expos
carboxyl
acid
end
group
presenc
diisopropylcarbodiimid
dic
hobt
substitut
dendrim
confirm
microcolorimetr
determin
use
modifi
resorcinolsulfur
acid
assay
microtit
plate
assay
wide
use
estim
percentag
sugar
substitut
neoglycoprotein
glycolipid
macromolecul
glycopolym
monomer
tetramer
octamer
polym
immobil
unto
seralos
gel
denot
seralosem
seraloset
seraloseo
gel
respect
purifi
goat
mpr
protein
cationindepend
receptor
separ
incub
gel
sdspage
analysi
elut
sampl
reveal
receptor
bound
gel
experi
confirm
previou
result
author
laboratori
glycodendrim
effect
use
adsorb
relat
affin
chromatographi
sinc
first
synthesi
dendrit
polym
late
grow
interest
hyperbranch
materi
alway
extend
uniqu
specif
properti
rel
convent
linear
branch
homolog
obtain
react
polyfunct
core
abx
monom
typic
ab
monom
yield
amorph
structur
obtain
macromolecul
thu
character
exponenti
growth
molecular
weight
endgroup
function
dendrit
polym
tradit
classifi
two
categori
dendrim
hyperbranch
polym
dendrim
character
perfect
symmetr
globular
shape
result
stepwis
control
process
give
monodispers
molecular
weight
distribut
second
categori
hyperbranch
polym
attract
resembl
dendrim
differ
lie
polydispers
lessperfect
globular
shape
produc
easili
larger
scale
reason
cost
thu
make
commerci
avail
larg
quantiti
nowaday
unlik
convent
polym
high
number
end
group
natur
particip
activ
physic
properti
solubl
glass
transit
temperatur
viscos
combin
backbon
structur
characterist
except
lead
possibl
design
macromolecul
combin
mani
differ
end
group
rojo
cowork
select
hyperbranch
dendrit
polym
name
boltorn
figur
second
third
fourth
gener
commerci
avail
low
cost
famili
dendrim
vari
number
hydroxyl
surfac
group
oh
group
oh
group
averag
dendrit
polym
base
monom
hydroxymethyl
propion
acid
function
mannosid
dendrit
alcohol
transform
carboxyl
acid
surfac
group
treat
polym
succin
anhydrid
presenc
dmap
pyridin
result
acid
mannosyl
via
amid
bond
unprotect
admannopyranosid
dcc
provid
mannodendrim
figur
ester
function
backbon
preclud
use
peracetyl
sugar
ensu
hyperbranch
dendrim
solubl
physiolog
condit
nontox
sever
cell
line
thirdgener
dendrim
show
nanomolar
inhibitori
properti
bind
ebola
viru
ebov
dcsign
highli
like
ebov
manner
similar
hiv
subvert
physiolog
role
dcsing
liverlymph
node
sign
lsign
achiev
import
step
infecti
process
receptor
critic
initi
step
viral
infect
mucos
level
subsequ
dissemin
throughout
bodi
dcsign
lsign
also
bind
ligand
contain
oligomannos
glycan
ctermin
crd
figur
boltorn
w
mannodendrim
obtain
amid
bond
coupl
use
ebola
bind
dcsign
mannosyl
dendrim
abl
select
inhibit
dcsignmedi
ebov
infect
effici
dosedepend
manner
ic
show
inhibitori
effect
infect
experi
use
dcsignneg
cell
line
anoth
assay
third
mannosyl
dendrim
inhibit
dcsign
bind
hiv
glycoprotein
ic
micromolar
rang
clearli
establish
ctype
lectin
consid
potenti
new
target
design
compound
act
viral
entri
inhibitor
ebov
hiv
model
studi
mannosebind
lectin
use
lectin
len
culinari
arc
et
al
demonstr
glycodendrim
perfectli
design
crosslink
solubl
receptor
also
obviou
membran
receptor
could
crosslink
glycodendrim
thu
lead
signal
phenomenon
previous
observ
glycopolym
glycodendrim
polyhydroxyl
natur
scaffold
demonstr
play
role
bind
interact
anoth
applic
hyperbranch
boltorn
polym
group
appli
versatil
click
chemistri
condit
azidofunction
boltorn
dendrim
touaibia
roy
unpublish
data
dendrim
obtain
treatment
hydroxyl
core
azido
acet
anhydrid
figur
ir
analysi
use
demonstr
complet
hydroxyl
group
transform
azid
function
introduct
click
hyperbranch
dendrim
obtain
typic
reaction
condit
cuso
sodium
ascorb
use
nonprotect
propargyl
amannosid
rel
inhibitori
potenc
click
dendrim
inhibit
agglutin
e
coli
yeast
mannan
approxim
time
higher
respect
methyl
mannosid
benhamioud
roy
unpublish
data
next
section
discuss
use
click
glycodendrim
exampl
illustr
analog
structur
systemat
prepar
stepwis
converg
approach
triazol
import
fivememb
nitrogen
heterocycl
involv
wide
rang
industri
applic
agrochem
corros
inhibitor
dye
optic
brighten
well
biolog
activ
agent
wellestablish
approach
prepar
triazol
ring
system
reli
thermal
huisgen
cycloaddit
alkyn
azid
figur
howev
noncatalyz
process
exhibit
sever
disadvantag
includ
requir
high
temperatur
condit
potenti
decomposit
labil
product
product
desir
triazol
gener
low
yield
poor
regioselect
given
fact
noncatalyz
cycloaddit
afford
mixtur
triazol
triazol
unless
alkyn
substitut
electronwithdraw
group
year
sever
effort
control
report
howev
regioselect
highyield
synthesi
triazol
via
cu
catalyz
cycloaddit
termin
alkyn
azid
recent
describ
figur
postul
coppercatalyz
click
reaction
proce
via
copperacetylid
intermedi
gener
cu
termin
alkyn
particip
anneal
process
upon
coordin
react
azid
although
cu
could
introduc
directli
form
differ
copper
salt
presenc
nitrogencontain
base
well
prior
exclus
oxygen
reaction
usual
requir
order
minim
format
undesir
byproduct
primarili
diacetylen
altern
catalyt
cu
speci
could
gener
situ
cuso
sodium
ascorb
latter
method
elimin
problem
byproduct
format
use
success
sever
differ
solvent
system
includ
water
method
need
prior
exclus
oxygen
presenc
nitrogen
base
could
abolish
recent
applic
reaction
azid
termin
alkyn
led
mani
interest
applic
click
reaction
includ
synthesi
natur
product
analog
although
azid
alkyn
display
high
mutual
reactiv
individu
function
group
two
least
reactiv
organ
synthesi
term
bioorthogon
stabil
inert
toward
function
group
typic
found
biolog
molecul
bioorthogon
allow
use
azidealkyn
cycloaddit
variou
biolog
applic
includ
targetguid
synthesi
activitybas
protein
profil
riguera
cowork
describ
quick
effici
reliabl
multival
conjug
unprotect
alkynederiv
carbohydr
three
gener
azidotermin
gallic
acidtriethylen
glycol
dendrim
figur
azideend
dendrim
via
success
peptid
coupl
reaction
amin
acid
obtain
reduct
azid
first
gener
bear
nine
azid
function
obtain
precursor
hydrogenolysi
pdcatalyz
condit
order
coupl
prefer
incorpor
termin
alkyn
potenti
cu
ii
catalyz
alkyn
oxid
homocoupl
may
give
rise
intramolecular
reaction
aqueou
condit
typic
click
chemistri
glycodendrim
contain
unprotect
mannos
fucos
lactos
residu
incorpor
respect
use
propargyl
mannosid
describ
practic
biolog
applic
glycodendrim
three
function
unit
usual
requir
target
moieti
biolog
activ
agent
probe
gener
facil
strategi
function
group
introduct
defin
posit
dendrim
best
achiev
dendrim
built
stepwis
synthes
figur
hawker
cowork
describ
fashioncontrol
strategi
toward
glycodendrim
two
distinct
moieti
target
detect
probe
place
chain
end
click
chemistri
use
key
step
thu
allow
simpl
origin
buildup
bifunct
dendrim
synthet
approach
base
hydroxymethyl
propion
acid
bismpa
acid
also
present
mannosyl
boltorn
hyperbranch
polym
propos
rojo
cowork
use
potenti
antivir
drug
see
boltornbas
glycodendrim
correspond
bismpa
anhydrid
provid
access
alkyn
ester
azid
ester
condens
appropri
alcohol
figur
remov
protect
group
subsequ
condens
cycloaddit
allow
gener
growth
core
afford
diol
focal
point
two
molecul
fluoresc
dye
introduc
esterif
two
free
hydroxyl
group
anhydrid
follow
cycloaddit
result
bisalkyn
acet
hydrolysi
subsequ
introduct
alkyn
via
esterif
follow
cycloaddit
unprotect
admannopyranosid
thfh
furnish
asymmetr
heterobifunct
dendrim
dendrim
test
standard
hemaglutin
assay
use
mbp
cona
rabbit
red
blood
cell
compar
mannos
activ
mannosyl
dendrim
exhibit
greater
potenc
rel
activ
per
sugar
moieti
use
microwav
irradi
organ
synthesi
becom
increasingli
popular
within
pharmaceut
academ
arena
new
enabl
technolog
drug
discoveri
develop
santoyogonzalez
cowork
use
organicsolubl
copper
complex
act
catalyst
allow
homogen
reaction
cycloaddit
among
copper
catalyst
alreadi
report
ph
p
cubr
eto
p
cui
chosen
due
especi
air
stabil
easi
inexpens
prepar
order
improv
cycloaddit
shorten
reaction
time
reaction
also
simultan
assist
use
microwav
irradi
figur
synthesi
tri
tetra
hexaval
mannopyranosyl
ligand
readili
obtain
use
carbohydr
noncarbohydr
aromat
azid
peracetyl
propargyl
mannosid
although
earlier
experi
reveal
reaction
peracetyl
mono
azido
per
azidobcyclodextrin
propargyl
thiopropargyl
mannosid
quit
slow
presenc
ph
p
cubrdipea
difficulti
overcom
addit
catalyt
amount
cui
mol
use
eto
pcuidipea
condit
bcyclodextrin
form
high
yield
experiment
procedur
microwaveassist
reaction
simpl
requir
microwav
irradi
evapor
solvent
prior
direct
purif
format
undesir
byproduct
never
observ
recent
pieter
et
al
use
extens
use
catalyst
cuso
vitamin
c
highyield
microwaveassist
triazolelink
glycodendrim
synthesi
figur
requir
anomer
glycosyl
azid
prepar
respect
peracetyl
counterpart
reaction
hbr
acoh
microwav
irradi
result
glycosyl
bromid
treat
trimethylsilyl
azid
use
microwav
afford
bazido
sugar
cycloaddit
dendron
bear
nine
propargyl
amid
achiev
galactos
glucos
cellobios
lactos
nonaval
glycodendrim
obtain
biolog
evalu
dival
glycoconjug
contain
fluoresc
probe
similarli
obtain
high
yield
obvious
approach
also
applic
mannosidebear
dendrim
fact
analog
architectur
compris
mannosid
prepar
microwaveassist
reaction
see
next
section
gallic
acid
acid
see
figur
common
scaffold
construct
glycodendrim
relat
architectur
initi
use
group
construct
sialodendrim
synthesi
lactosyl
dendrim
advantag
permit
faster
growth
dendrim
gener
sinc
expos
function
group
valenc
start
n
interest
seed
molecul
calix
aren
calyx
resorcaren
porphyrin
triphenylen
hexasubstitut
benzen
see
follow
section
anoth
interest
structur
base
polyphenylen
also
recent
publish
sakamoto
mullen
use
key
dielsald
reaction
use
aromat
core
group
pieter
describ
synthesi
multival
mannosid
inhibitor
type
fimbriat
uropathogen
e
coli
benzoic
acid
scaffold
use
repeat
unit
carboxyl
acid
moieti
introduc
onto
carbohydr
thu
enabl
peptid
coupl
mono
bisand
multival
aminofunction
aromat
scaffold
give
dendron
figur
mannosyl
dendrim
test
rel
inhibitori
potenc
use
develop
elisa
test
discuss
pamam
section
mannos
poor
inhibitor
bind
e
coli
urinari
cell
line
ic
increas
number
mannosid
residu
greatli
improv
affin
absolut
valu
ic
tetram
rel
term
express
per
mannosid
basi
iv
al
en
c
om
po
un
elong
spacer
show
highest
rel
potenc
per
sugar
basi
enhanc
ic
mannosyl
polym
analog
structur
good
dimer
converg
methodolog
see
figur
use
stoddart
cowork
involv
essenti
synthesi
dendrit
wedg
possess
admannopyranosid
figur
aromat
core
scaffold
multival
mannosid
cluster
use
inhibit
bind
e
coli
human
urotheli
cell
line
branch
region
dendrit
wedg
deriv
tri
hydroxymethyl
aminomethan
glycosyl
three
hydroxyl
group
gave
trisbranch
mannosid
possess
amin
end
group
dendron
tetraacid
deprotect
afford
dendron
mannosid
residu
final
branch
wedg
attach
aromat
core
deriv
chlorid
format
amid
bond
presenc
dcchobt
figur
result
glycodendrim
mannosid
residu
next
evalu
biolog
potenc
glycodendrim
evalu
ella
involv
inhibit
cona
bind
purifi
yeast
mannan
fraction
fraction
interest
strong
bind
antibodi
found
serum
patient
crohn
diseas
time
methyl
admannopyranosid
ic
similar
activ
compar
molar
basi
activ
much
greater
suggest
homogen
monodispers
dendrim
cluster
effect
pronounc
glycodendrim
show
inhibit
bind
antibodi
found
serum
crohn
patient
recogn
yeast
mannan
fraction
mention
aromat
scaffold
use
seed
molecul
extens
use
calix
aren
calyx
resorcaren
porphyrin
triphenylen
hexasubstitut
benzen
calix
aren
calyx
resorcaren
particular
interest
sinc
potenti
act
carrier
virtu
caviti
pentaerythritol
simpl
fivecarbon
tetraol
use
fabric
resin
alkyl
resin
varnish
pvc
stabil
tall
oil
ester
olefin
antioxid
also
known
name
hercul
monopentaerythritol
tetramethylolmethan
thme
petp
pentaerythrit
pentek
etc
pentaerythritol
interest
compound
allow
attach
four
similar
differ
group
henc
construct
highli
branch
structur
accordingli
compound
receiv
consider
interest
orthogon
protect
handl
use
gener
combinatori
librari
build
block
fit
well
gener
structur
oligonucleotid
peptid
provid
addit
function
inhibit
mannosespecif
bacteri
adhes
lindhorst
cowork
design
pentaerythritolbas
clustermannosid
shown
figur
pentaerythritol
well
includ
spacer
use
structur
element
monosaccharid
moieti
first
rout
hydroxi
linker
introduc
within
aglycon
moieti
williamson
ether
synthesi
commerci
avail
pentaerythritol
tetrabromid
led
mixtur
mono
di
tri
tetradent
product
even
eightfold
excess
alcohol
forc
reaction
condit
use
figur
best
case
tetraval
cluster
isol
yield
altern
rout
target
tetramer
cluster
investig
pentaerythritol
modifi
serv
spacerequip
tetrafunct
core
molecul
subsequ
glycosyl
step
end
pentaerythritol
initi
per
allyl
extend
tetraol
obtain
oxid
ozonolysi
naoh
h
perbenzoyl
mannosyl
trichloroacetimid
use
glycosyl
donor
protect
tetramannosid
isol
excel
yield
lindhorst
cowork
also
synthes
seri
trisaccharid
mimet
serv
ligand
type
fimbrial
adhesin
glycoclust
either
obtain
eedq
assist
peptidecoupl
reaction
triacid
mannosid
without
protect
provid
trival
mannosid
figur
procedur
success
use
obtain
cluster
bear
methyl
pnitrophenyl
aglycon
branch
amino
posit
latter
interest
aromat
moieti
increas
affin
given
carbohydr
ligand
lectin
receptor
hydrophob
interact
inhibitori
potenc
pnitrophenyl
admannosid
pnpman
approxim
time
higher
respect
methyl
mannosid
cluster
r
ch
show
ic
surpass
inhibitori
potenc
cluster
contain
pnpman
spacermodifi
mannosid
reveal
interest
success
inhibit
fimbriaemedi
adhes
e
coli
high
mannosetyp
surfac
none
compound
reach
inhibitori
potenc
r
ch
result
howev
somewhat
surpris
given
fact
fimbriat
e
coli
fimh
prefer
bind
mannosid
nonreduc
end
see
figur
thu
provid
room
cluster
enter
activ
site
reduc
end
mention
highmannos
type
nglycan
repres
valuabl
target
wide
rang
biolog
applic
linear
trimannosid
introduc
sequenti
onepot
reaction
onto
extend
pentaerythritol
langer
et
al
sequenc
reiter
reaction
toward
extend
tetraol
precursor
involv
two
cycl
pentaerythritol
allyl
follow
oxid
hydrobor
mannosyl
tetraol
protect
trimannosyl
selenid
donor
provid
deprotect
valuabl
tetram
shown
figur
unfortun
biolog
data
given
prepar
glycosylamin
direct
condens
amin
reduc
sugar
well
describ
literatur
condens
small
rang
reduc
sugar
diamin
also
previous
report
allow
effici
rapid
access
dival
carbohydr
deriv
excel
yield
hay
cowork
describ
onepot
methodolog
allow
synthesi
higher
valent
deriv
reaction
highli
function
amin
cluster
admannos
multival
carbohydr
sever
linker
differ
length
flexibl
valenc
readili
incorpor
allow
onepot
entri
desir
target
good
yield
pentaerythritol
tetraamin
prepar
reduct
tetraazido
pentaerythritol
hydrogen
pdc
gave
tetramannosid
cluster
reduc
mannos
figur
extens
reduct
amin
strategi
also
possibl
construct
hexam
figur
combin
aldehyd
tri
ethylamino
amin
sodium
triacetoxyborohydrid
recent
report
describ
synthesi
nonaval
glycodendrim
admannopyranosid
unit
trival
mannosyl
dendron
prepar
glycosyl
pentaerythritol
deriv
three
hydroxyl
group
tripl
sonogashira
coupl
reaction
dendron
triopropargyl
ether
gave
nonaval
glycodendrim
excel
yield
figur
approach
repres
anoth
versatil
extens
synthesi
rigid
glycodendrim
use
transit
metal
catalyst
figur
trimannosid
pentaerythritolbas
cluster
use
onepot
assembl
extend
pentaerythritol
scaffold
naom
figur
synthesi
nonaval
glycodendrim
use
tripl
sonogashira
coupl
multifunct
natur
monosaccharid
oligosaccharid
combin
inher
stereochemistri
glycosid
linkag
increas
potenti
structur
divers
attain
sugar
use
scaffold
respect
carbohydr
far
surpass
potenti
peptid
nucleotid
oligom
multival
build
block
lindhorst
cowork
describ
synthesi
carbohydratecent
glycoclust
incorpor
spacer
arm
allow
conjug
oligosaccharid
mimet
figur
thu
dglucos
trehalos
use
core
molecul
start
glucos
pentaacet
tetrasubstitut
glucosid
obtain
sequenc
reaction
involv
glycosyl
catalyz
bf
ether
follow
bromid
substitut
azid
anion
acet
deprotect
perallyl
ptc
condit
result
tetraallyl
glucosid
treat
oxid
hydrobor
condit
naoh
h
give
desir
glucosebas
mannoclust
obtain
glycosid
deprotect
perbenzoyl
mannosyl
trichloroacetimid
termin
amino
function
tether
mannosid
cluster
allow
attach
probe
biotin
fluoresc
dye
coupl
solid
support
order
provid
matric
affin
chromatographi
attempt
toward
similar
treatment
nonreduc
disaccharid
trehalos
construct
analog
octamer
dendron
met
sever
difficulti
altern
octaol
could
easili
obtain
hydrobor
octaoallyltrehalos
mannosyl
monosaccharid
approach
follow
cleavag
interglycosid
linkag
intermedi
stage
synthesi
use
bf
ether
afford
two
equival
reduc
glucosecent
mannoclust
appropri
transform
gave
amino
tetram
figur
altern
aminofunction
trehalos
core
obtain
group
reduct
ozonolysi
octaallyl
trehalos
deriv
follow
reduct
amin
ensu
octaaldehyd
result
amino
trehalos
treat
isothiocyan
octaval
thioureabridg
mannos
cluster
obtain
deprotect
figur
exampl
includ
cyclodextrin
scaffold
see
discuss
interest
variant
eleg
strategi
put
forward
wang
cowork
synthesi
candid
vaccin
base
high
recognit
multiantennari
mannosid
neutral
human
antibodi
see
construct
hyperbranch
mannosid
four
posit
galactosid
deriv
four
maleimido
group
introduc
onto
perallyl
galactosid
bear
thelper
cell
epitop
anomer
posit
ligat
maleimidofunction
scaffold
known
shtag
man
glcnac
asn
provid
key
immunogen
obtain
antisera
weakli
crossreact
major
igg
antibodi
direct
linker
glycoconjug
although
except
silan
still
consid
specialti
product
synthesi
biolog
activ
compoud
industrialscal
product
agrochem
growth
literatur
report
applic
patent
regard
util
suggest
demand
applic
rise
next
year
carbosilan
compound
element
carbon
silicon
occupi
altern
posit
molecular
framework
glycoconjug
possess
carbosilanebas
saccharid
surfac
first
introduc
matsuoka
cowork
lindhorst
cowork
report
heteroatomfre
connect
carbohydr
carbosilan
scaffold
carbosiloxan
gener
form
treatment
chlorosilan
alcohol
compon
presenc
base
moder
yield
type
reaction
like
due
steric
hindranc
second
reactiv
chlorin
one
silicon
atom
initi
attack
first
alcohol
deriv
better
procedur
involv
hydrosilyl
reaction
put
forward
use
wellknown
platinumcatalyz
hydrosilyl
reaction
alken
suitabl
hydrosilan
deriv
togeth
power
catalyst
silopren
bayer
ag
platinumsiloxan
complex
allyl
mannosid
acet
desir
isopropylideneprotect
siladendrim
obtain
deprotect
acet
methanol
hcl
provid
unprotect
carbosilan
glycoclust
figur
introduct
mannos
deriv
terunuma
cowork
use
three
carbosilan
dendrim
scaffold
three
four
sixbranch
figur
bromid
zerogener
scaffold
respect
prepar
triallylphenylsilan
tetraallylsilan
follow
three
reaction
step
hydroxyl
mesyl
bromin
hand
bromid
repres
firstgener
carbosilan
dendrim
scaffold
prepar
allyl
dichlorodimethylsilan
follow
hydrosilyl
firstgener
skeleton
protect
mannos
disaccharid
synthes
start
dmannos
use
standard
protocol
figur
glycosyl
acetobromomannos
presenc
agotf
proceed
stereoselect
deprotect
result
disaccharid
aqueou
tfa
acetyl
allyl
bf
diether
radicalinduc
thioacetyl
provid
desir
disaccharid
unprotect
man
disaccharid
coupl
carbosilan
dendrim
scaffold
complet
deacetyl
use
sodium
methoxid
nucleophil
displac
bromid
sugar
thiolat
reoacetyl
requir
purif
purpos
gel
permeat
chromatographi
gpc
mannoseco
carbosilan
dendrim
obtain
disulfid
byproduct
remov
bind
correspond
tri
tetra
hexaval
ligand
dimer
lectin
cona
ph
evalu
titrat
microcalorimetri
itc
solubl
protein
titrat
aliquot
solubl
ligand
measur
heat
produc
ligand
addit
serv
report
signal
bind
give
bind
constant
turn
could
relat
free
gibb
energi
bind
sinc
techniqu
also
directli
measur
bind
enthalpi
entropi
bind
could
evalu
carbosilan
dendrim
show
higher
bind
constant
valu
con
nondendrit
mannos
deriv
meaman
thu
demonstr
cluster
glycosid
effect
magnitud
effect
depend
amount
mannos
given
dendrim
case
threebranch
dendrim
peripher
mannosid
valu
carbosilan
dendrim
substanti
higher
noncarbosilan
dendrim
anoth
recent
report
gao
et
al
describ
facil
effici
prepar
glycoclust
silsesquioxan
unprotect
thiolat
mannosid
directli
coupl
radic
reaction
octavinyl
poss
core
provid
glycoclust
approxim
yield
gel
filtrat
purif
figur
strategi
equal
appli
galactosid
lactosid
use
galactos
specif
ricinu
communi
agglutinin
octaval
cluster
shown
complet
inhibit
bind
asialooligosaccharid
human
acid
glycoprotein
thu
glycosid
cluster
effect
famili
compound
show
time
better
affin
correspond
monom
solidphas
organ
synthesi
rapidli
expand
area
synthet
chemistri
wide
exploit
search
new
biolog
activ
compound
combinatori
techniqu
origin
develop
peptid
synthesi
oligonucleotid
synthesi
wide
appli
oligosaccharid
chemistri
combinatori
chemistri
appli
solidphas
techniqu
broadli
use
organ
synthesi
takahashi
cowork
report
eleg
solidphas
combinatori
synthesi
carbohydr
cluster
treetyp
linker
subsequ
orthogon
cleavag
provid
dimer
tetram
figur
figur
silsesquioxanesbas
glycodendrim
obtain
radic
addit
bromid
bisazido
alcohol
two
phase
condit
gave
desir
tetraazid
upon
stauding
reduct
aqueou
pph
follow
fmoc
protect
result
amin
provid
intermedi
format
resinload
treetyp
dendron
precursor
success
achiev
thp
deprotect
attach
amin
resin
succinyl
treatment
bromoacet
acid
dic
hobt
fmoc
deprotect
piperidin
dmf
tetramer
mannosyl
cluster
obtain
standard
alkalin
condit
use
thioether
format
thiomannosid
final
tetramer
glycoclust
releas
resin
alkalin
treatment
provid
interestingli
dimer
glycoclust
could
also
releas
resin
acid
treatment
acetylenicco
co
complex
nichola
reaction
tetram
inhibit
bind
fluoresceinlabel
mannosyl
bovin
serum
albumin
bsa
onto
periton
exud
macrophag
particular
interest
section
find
lehn
appeal
dynam
combinatori
carbohydr
librari
librari
gener
array
thiolat
mannosid
structur
linker
vari
result
thiol
deriv
allow
randomli
oxid
disulfid
vari
composit
librari
member
thu
gener
mannodim
evalu
cona
inositol
deriv
becom
increasingli
recogn
import
build
unit
dozen
new
aminocyclitol
antibiot
intracellular
messeng
histor
featur
promin
develop
modern
idea
conform
energi
symmetri
properti
hard
give
cours
stereochemistri
without
discuss
scylloinositol
allequatori
stereoisom
myoinositol
select
chung
cowork
scaffold
glycodendrim
synthesi
amino
scylloinositol
scaffold
constitut
key
intermedi
subsequ
glycosyl
well
chain
elong
multipl
desir
dendrimer
gener
figur
addit
triamin
excess
methyl
acryl
follow
amid
result
ester
ethylenediamin
afford
amidoamin
dendrim
condit
previous
seen
synthesi
pamam
dendrim
reiter
twostep
reaction
sequenc
success
result
doubl
peripher
amino
function
toward
glycoconjug
dendrim
achiev
use
previous
discuss
thiourea
linkag
base
mannosyl
isothyocyan
anoth
option
make
glycodendrim
take
converg
rout
start
monosaccharid
small
glycoclust
attach
branch
unit
final
suitabl
core
shown
figur
fernandez
cowork
describ
synthesi
glycodendrimercyclodextrin
structur
provid
biolog
evalu
cona
sever
oligosaccharidebranch
cyclodextrin
also
report
past
year
cyclodextrin
particularli
wellsuit
glycoclusterlectin
studi
sinc
abil
complex
small
hydrophob
molecul
drug
caviti
key
templat
deoxybcyclodextrin
modifi
branch
element
isothiocyanatofunction
admannopyranosyl
cluster
prepar
trisamin
tri
coupl
isothiocyan
aminefunction
trimannosid
branch
element
gave
thioureabridg
glycodendrimercyclodextrin
conjug
figur
monosubstitut
hexaval
bcyclodextrin
mannodendrim
show
strong
cluster
effect
toward
con
ayeast
mannan
interact
ic
repres
increas
molar
basi
compar
monoval
deriv
cyclodextrin
deriv
exhibit
extrem
high
water
solubl
higher
compar
parent
cyclodextrin
taxol
solubil
aqueou
solut
trival
cyclodextrin
deriv
c
respect
solubl
enhanc
compar
water
solubl
drug
result
illustr
superior
potenti
dendrit
cyclodextrin
drug
carrier
differ
approach
radic
photoaddit
glycothiol
allow
stoddart
cowork
achiev
simultan
attach
saccharid
moieti
shown
structur
figur
calixaren
cyclic
molecul
contain
caviti
use
hostguest
chemistri
intrins
amphiphil
architectur
also
make
ideal
candid
studi
watermonolay
surfac
interact
respect
surpass
cyclodextrin
counterpart
kim
roy
describ
first
synthesi
dendrit
watersolubl
carbohydratecontain
ptertbutylcalix
aren
lectinbind
properti
carbohydratecontain
calix
aren
serv
model
investig
factor
influenc
multival
carbohydrateprotein
interact
molecular
level
lipophil
ptertbutyl
substitu
provid
drive
forc
stabl
assembl
andor
adhes
calixaren
monolay
hydrophob
surfac
hydrophil
carbohydr
tail
mimick
cell
sacchariderich
surfac
present
cancer
tissu
n
antigen
new
type
hybrid
molecul
serv
coat
materi
carbohydr
ligand
competit
solidphas
immunoassay
hexadecamer
glycocalix
aren
obtain
octamer
amin
bromoacetamidogalnac
deriv
deoacetyl
figur
tetra
octaand
hexaoctacalix
aren
glycodendrim
evalu
rel
lectinbind
properti
vicia
villosa
agglutinin
vva
plant
lectin
use
previous
bind
studi
adgalnac
deriv
direct
bind
abil
crosslink
behavior
calix
aren
ligand
toward
vva
determin
turbidimetr
analysi
hyperval
glycocalix
aren
dendrim
demonstr
direct
bind
vva
rapid
format
insolubl
precipit
effici
glycocalixaren
inhibit
bind
asialoglycophorin
natur
glycoprotein
human
erythrocytesblood
group
serotyp
measur
ella
best
result
obtain
hexadecaval
conjug
ic
repres
increas
potenc
allyl
adgalnac
monom
ic
prepar
glycocalixaren
deriv
also
directli
adsorb
onto
lipophil
surfac
polystyren
microtit
plate
thu
use
bioanalyt
devic
ptertbutylcalix
aren
also
use
roy
meunier
synthesi
asialylatedcalix
aren
evid
strong
crosslink
abil
tetramer
wheat
germ
agglutinin
wga
plant
lectin
known
bind
sialosid
detect
tetram
glycerol
also
use
scaffold
glycodendrim
synthes
report
describ
synthesi
four
mannosecontain
residu
figur
compound
evalu
capac
inhibit
mannosespecif
adhes
e
coli
use
recombin
strain
e
coli
hb
express
type
fimbria
surfac
unfortun
none
test
cluster
better
inhibitor
pnpman
stoddart
cowork
describ
multival
glycodendrim
base
triphenylen
core
figur
dendrim
methylen
linker
core
glycodendron
end
group
form
hexagon
columnar
structur
gave
rise
fluid
birefring
textur
c
figur
monosubstitut
bcyclodextrin
scaffold
uniqu
hexamer
mannosid
cluster
caviti
portion
bcd
use
carri
anticanc
drug
taxol
water
solubl
greatli
improv
construct
figur
glycodendrim
bear
triphenylen
core
sugar
appendag
show
liquid
crystal
behavior
enorm
creativ
inject
field
glycodendrim
synthes
allow
prepar
mani
vari
structur
beauti
architectur
unless
otherwis
state
report
present
involv
mannosid
residu
hope
sensit
commun
broad
arsen
molecul
avail
perhap
stimul
other
come
spite
fact
rel
novel
famili
small
macromolecul
discov
somewhat
surpris
still
architectur
rule
govern
synthesi
best
candid
given
applic
person
experi
could
conclud
glycopolym
still
repres
effici
candid
target
viral
particl
howev
scarc
inform
avail
appear
dendron
glycopolym
might
offer
clear
advantag
situat
seem
dramat
differ
deal
fimbriat
bacteria
certainli
multimer
solubl
carbohydratebind
protein
lectin
galectin
antibodi
also
somewhat
surpris
commun
yet
concent
use
bacteri
strain
deal
inhibit
adhes
fimbriat
e
coli
relat
pathogen
situat
remedi
near
futur
one
want
establish
govern
rule
design
better
improv
adhes
inhibitor
gener
inform
hand
tend
indic
glycodendrim
better
glycopolym
bind
fimh
fimbriat
e
coli
addit
longer
rigid
linker
brought
notic
improv
also
clear
given
situat
optim
key
monoval
sugar
investig
prior
parallel
make
multival
cluster
everincreas
field
nanotechnolog
appli
glycobiolog
certainli
allow
novel
architectur
come
realiti
regard
fulleren
carbon
nanotub
gold
nanoparticl
quantum
dot
like
repres
stimul
carrier
candid
particular
applic
inher
physic
spectroscop
properti
novel
basic
materi
like
properli
conjug
suitabl
carbohydr
motif
afford
glycomateri
useabl
nanomedicin
vaccin
drug
deliveri
topic
cure
vast
access
inform
avail
regard
new
glycodendrim
thorough
biolog
investig
design
cellular
toxic
certainli
area
behind
schedul
glycodendrim
cell
permeabl
vari
structur
motif
sugar
composit
also
remain
investig
merg
sever
glycoscientist
work
togeth
futur
look
bright
glycodendrim
state
n
sharon
cowork
two
decad
ago
realm
use
sugar
bacteri
antiadhes
molecul
final
touchabl
